INSM · INSMED Inc · Documents

Feb 20

Earnings call

Q4 2024 earnings call

Feb 20

Current report 8-K Events of Feb 18

Financial results, Director or officer change, or executive pay

Feb 20

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $363.71M ▲ 19.2% Net loss $913.77M Diluted EPS -$5.57

Feb 6

Current report 8-K

Regulation FD disclosure, Other events

Jan 10

Current report 8-K

Regulation FD disclosure

Nov 19

Current report 8-K Events of Nov 18

Ended a material agreement

Oct 31

Earnings call

Q3 2024 earnings call

Oct 31

Current report 8-K

Entered into a material agreement, Financial results, New debt or off-balance-sheet obligation

Oct 31

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $93.43M ▲ 18.2% Net loss $220.52M Diluted EPS -$1.27

Aug 9

Current report 8-K

Other events

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $90.34M ▲ 17.0% Net loss $300.61M Diluted EPS -$1.94

Jul 3

Current report 8-K

Regulation FD disclosure

Jun 27

Current report 8-K

Other events

Jun 13

Current report 8-K Events of Jun 12

Other events

Jun 4

Current report 8-K

Regulation FD disclosure

May 30

Current report 8-K Events of May 29

Regulation FD disclosure, Other events

May 28

Current report 8-K

Regulation FD disclosure, Other events

May 13

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

May 9

Earnings call

Q1 2024 earnings call

May 9

Current report 8-K

Financial results, Other events

May 9

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $75.5M ▲ 15.8% Net loss $157.09M Diluted EPS -$1.06

Apr 1

Proxy statement DEF 14A Meeting May 13, 2024

Proxy statement

Apr 1

Proxy statement DEFA14A

Proxy statement

Mar 11

Current report 8-K Events of Mar 8

Other events

Feb 22

Earnings call

Q4 2023 earnings call

Feb 22

Current report 8-K

Entered into a material agreement, Ended a material agreement, Financial results

Feb 22

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $305.21M ▲ 24.4% Net loss $749.57M Diluted EPS -$5.34

Jan 5

Current report 8-K

Regulation FD disclosure

Oct 26

Earnings call

Q3 2023 earnings call

Oct 26

Current report 8-K

Financial results

Oct 26

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $79.07M ▲ 16.7% Net loss $158.93M Diluted EPS -$1.11

Sep 5

Current report 8-K

Regulation FD disclosure

Aug 3

Earnings call

Q2 2023 earnings call

Aug 3

Current report 8-K

Financial results

Aug 3

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $77.23M ▲ 18.4% Net loss $244.81M Diluted EPS -$1.78

Jul 7

Current report 8-K/A Events of May 11

Shareholder vote results

May 19

Registration statement S-3ASR

Registration statement

May 11

Current report 8-K

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 8

Current report 8-K

Regulation FD disclosure

May 4

Earnings call

Q1 2023 earnings call

May 4

Current report 8-K

Financial results

May 4

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $65.21M ▲ 22.8% Net loss $159.76M Diluted EPS -$1.17

Mar 31

Proxy statement DEF 14A

Proxy statement

Mar 31

Proxy statement DEFA14A

Proxy statement

Feb 23

Earnings call

Q4 2022 earnings call

Feb 23

Current report 8-K

Financial results

Feb 23

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $245.36M ▲ 30.2% Net loss $481.53M Diluted EPS -$3.91

Jan 6

Current report 8-K

Regulation FD disclosure

Oct 27

Earnings call

Q3 2022 earnings call